Lung Cancer Virtual Program
Meeting Host
AstraZenecaDescription
- A Treatment Option for Certain Patients With Unresectable Stage III NSCLC
- Perioperative Immunotherapy + Neoadjuvant Platinum-Containing Chemotherapy for the Treatment of Resectable NSCLC
When
Wednesday, November 20, 2024
6:00 PM ET
Speaker
Chandar Bhimani, MD
Hematologist/Oncologist
Northwest Georgia Oncology Center
Registration
To participate virtually, register at:
https://qr.short.az/EVT-20207402
RSVP
Allyson Campbell
404-578-4799
Allyson.Campbell@astrazeneca.com
